Name | isopentadecanoic acid |
---|---|
Synonyms |
13-Methylmyristic acid
13-METHYLTETRADECANOIC ACID 13-Methyltetradecanoic acid |
Description | 13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid with potent anticancer effects. 13-Methyltetradecanoic acid induces apoptosis in many types of human cancer cells[1][2]. |
---|---|
Related Catalog | |
In Vitro | 13-Methyltetradecanoic acid (13-MTD; 0-140 μg/mL; 12-24 hours) inhibits cell viability and proliferation in human bladder cancer cells by inducing apoptosis[1]. 13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-48 hours) treatments results in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner, with the proportion of sub-G1 phase DNA content ranging from 9.25% to 85.3% over 2-48 hours[1]. 13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-24 hours) down-regulates Bcl-2 and up-regulates Bax. This promotes mitochondrial dysfunction, leading to the release of cytochrome c from the mitochondria to the cytoplasm, as well as the proteolytic activation of caspases. 13-Methyltetradecanoic acid down-regulates AKT phosphorylation and activates phosphorylation of p38 and c-Jun N-terminal kinase (JNK)[1]. Cell Viability Assay[1] Cell Line: Bladder cancer cell lines T24, 5637, and UM-UC-3 Concentration: 0 μg/mL, 35 μg/mL, 70 μg/mL, 105 μg/mL, and 140 μg/mL Incubation Time: 12 hours, 24 hours Result: Inhibition of cell viability in a dose- and time-dependent manner. Cell Cycle Analysis[1] Cell Line: Bladder cancer cell lines T24, 5637, and UM-UC-3 Concentration: 70 μg/mL Incubation Time: 2 hours, 8 hours, 24 hours, or 48 hours Result: Resulted in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner. Western Blot Analysis[1] Cell Line: T24, 5637, and UM-UC-3 cells Concentration: 70 μg/mL Incubation Time: 2 hours, 8 hours, 24 hours Result: Down-regulated Bcl-2 and up-regulated Bax, and down-regulated AKT phosphorylation and activated phosphorylation of p38 and c-Jun N-terminal kinase (JNK). |
In Vivo | 13-Methyltetradecanoic acid (13-MTD; 70 mg/kg/day; oral gavage; daily; for 30 days) significantly suppresses tumor growth in a xenograft model[2]. Animal Model: BALB/C nude mice injected with Jurkat lymphoma cells[2] Dosage: 70 mg/kg/day Administration: Oral gavage; daily; for 30 days Result: Effectively inhibited the growth in vivo in a xenograft model. |
References |
Density | 0.894 g/cm3 |
---|---|
Boiling Point | 355.5ºC at 760 mmHg |
Molecular Formula | C15H30O2 |
Molecular Weight | 242.40 |
Flash Point | 197.4ºC |
Exact Mass | 242.22500 |
PSA | 37.30000 |
LogP | 5.01810 |
Vapour Pressure | 5.19E-06mmHg at 25°C |
Index of Refraction | 1.451 |
Storage condition | 2-8°C |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | 36/37/38 |
Safety Phrases | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2915900090 |
Precursor 8 | |
---|---|
DownStream 5 | |
HS Code | 2915900090 |
---|---|
Summary | 2915900090 other saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:5.5% General tariff:30.0% |